System Investor Relations. On the company, we have Bernard Charlotte, our Vice Chairman, Chief Executive Officer and Pascal Daloz, Chief Financial And Chief Strategy Officer. I would like to welcome you to Dassault System, third quarter 2019 earnings presentation made which is also being webcast. At the end of the presentation, we'll take questions from the audience and from participants on the webcast's call. Later today, we'll also hold a conference call.
Dassault Systemes results are prepared in accordance with IFRS. We adopted IFRS 15 in 2018, so all comparative information is presented under IFRS 15. In addition, we adopted the new call are presented on a non IFRS basis with revenue growth rates in constant currencies, unless otherwise noted. For an understanding of the differences between the IFRS and non IFRS, please see the reconciliation tables included in our press release. Some of the comments we'll make during today's presentation will contain forward looking statements, which could differ materially from actual results.
Please refer to our risk factors in our 2018 Docomo Affairs. Let me now introduce Bernard Thomas.
Thank you, Francois Jose. Good morning to everyone. There are sometimes good nights on things coming together. I mean, last night, we got the finally, the secure approval for Medidata. So, we are pleased with that.
So, it fits very well in terms of timing to prepare the next year planning. So that's a good news. We will be able to Viville much more at the next analyst meeting, of course, but let's talk about Q3 here. What you will notice is good progression of the revenue. The news flow this quarter is very important and should not be looked at from a quarter relevancy, but from a midterm, long term decision process, and I will come back to that with some of the major decision from customers.
Revenue is up 12%. Organic gross revenue is up 9% on the software revenue for the 3 d experience is up 22%, sorry, as well as a double digit growth in aerospace, Marine And Offshore, and on lifestyle connecting that to Centric PLF. And, so we are on track, I think, for the 2019 2014, 2019 5 years plan to deliver 1,000,000 of EPS, doubling the EPS, as we said. So, the planning was not was good. The Medidata acquisition will be closed in the next coming days.
Thank you, our team to be here. Representative of Medidata, we will have time to celebrate in a few weeks from now. And we are adding Spaskal will provide you more details. We are adding 2 months activity of Medidata for the full year plan of Dassault Systemes So from a purpose standpoint, I think we are right at the middle of what it means, harmonizing product nature on life means that we need to do more in life science. From the, impact on our platform application for industry development.
I think there is a very strong dynamic from both very large scale companies as well as very small companies. And I will try to illustrate some of this going on, thanks to the cloud and also the financial model, the business model with recurring revenue and subscription. And The, when you think about the kind of product on service we deliver now, I think it's good to keep in mind that moving forward with the portfolio, we are becoming customer centric, of course, for growing companies developing customer experience to their own customers, cities and centric, with platform for cities, and passion centric for, the health environment. So those are the highlights for what could be relevant in terms of announcement for this quarter. You are familiar with our purpose.
I will not go all the detail now, but I think there is a formidable reason to believe that the bio science and life science is becoming the next core sector for Dassault System with, maybe they down the bio via dynamic, by the way, that I will also mention. What are, consultation and mobility? There was with based on the news flow of volume production going down in slow and being slow in the transportation and mobility sector, there were there are some concerns about that sector for itself. Please remember that most of the players in the world have announced massive reorganization of your portfolio, whether it's about electrification, I'm thinking about Audi a few weeks ago, let's say that by 2025, which is for product development today, when you think about 2025 deliveries, or they want to have half of their portfolio being electrified whether hybrid or, and also connected. So the dynamic in terms of product portfolio, number of programs under development is very strong.
Whether you look at connectivity, electrical certification and technology, whether you could look at the certification and compliance program, or you look at, of course, the battery technology per se, as well as the new architecture for vehicle because the vehicles with electrification do not have the same architecture as vehicle with additional engines. And the flexibility on underground systems, plans in manufacturing, auto sectors are going to see significant new type of digitalization because you don't produce those cars the same way. I was pleased to see that this guy is now in the green, which is we've worked a lot with them, for, for, for many years past years. So those are the key trends you see here, them. That news, from Toyota is, I think, a significant news because it's the platformization of the entire product development production on SARS.
So we're not communicating about a purchase order here. We are communicating about a significant decision for the sector. On, as we have communicated, the Toyota has made the decision to use our platform for the entire lifecycle using platform based processes as opposed to PDM based product development in order to transform the way our company is working. This was a long expected decision. We've worked a lot with them in the last 2 years.
I think it will have significant influence for the Japanese industry and a major influence for the entire auto sector. On the other extreme, As you may remember, if you really track, look at the log of all the wins we have in with the new backups in the e mobility. We have almost won all of them. And they are doing real things on the cloud with our solutions Spark is a good example of Spark Racing, where they are really redesigning on creating new type of vehicle. This is for formula e Racing.
But they are also demonstrating how the electrical technology will evolve for regular cars And there is a quite interesting video, I think, just here that I want you to watch. Uh-huh.
And formally e demonstrates that electric cars are the future of the automobile. In the beginning, there was no formulating there were no races, teams, or race car drivers, and a couple of crazy guys said it was possible to build 40 electric race cars. Hence wise, Spark Racing Technology was born. Company today, Formula Beach features the only fully electric competition car.
Yeah. Yeah. Quickly. We went
from a single model formula where all the teams were using the same car provided by Spark to a champion that brings together 9 international car manufacturers competing with their own powertrain and demonstrating their know how and electric drive. The big step taken by formerly Eve was completing a full race without a pit stop, without a car change, and with a single battery charge. To make this project a success, we need the tools that would allow us to go as fast as our ambitions and that's what we found through 3 d experience. We saved time and we also entered new markets related to the electric drive and automobile fields. Thus Spark has already changed the game by building the first electric competition car.
It will definitely change the vision of the race car, but also of the everyday car.
See them,
where the future is electric.
Speed on capacity to change full architecture on integration between electronic software. On new material science for this kind of technology or this kind of startups. I think this will have a big impact for big players. And we see it with many of them already. So the platform phenomenon is real but phenomenon.
In aerospace, the same phenomenon is happening. Production rate, of course, on the capacity to expand on that aspect. The management of complexity on the new type of innovation as well as service to airlines. And I think that No. Boeing demonstrated the adoption of the 3DEXPERIENCE platform.
It's going on. Airbus made the same decision. And I think, in the defense sector, the decision by Lockheed Martin to really transform for the next generation of secret programs is, for us, a very significant event, those are extreme technology companies doing extreme vehicles. And many of them are really so special, but the platform adoption is really, not again, an instant revenue generation, but a major decision for the future of this sector. SAS another example, which really expands on the cloud, those are, they are really using the full digital virtual twin experience for kitchen.
In, on, on really food systems, and we are doing forecasting of ingredients on it's quite big companies and they are providing services to the airports on airports on big infrastructure. So the value here is how can you use a platform to create a full digital twin experience of your operation and optimize them through the platform consistency. It's a great showcase. I think this customer is really making the difference Consumer packaged goods, this time we look at this. I know that I've been observing the performance in the sector, We, of course, always look at our customer's performance to look at where things and the trends and what they need.
So in that sector of CPG or fast moving consumer goods, a lot of transformation happening, especially with the sensitivity of green consumer behavior, which are impacting massively packaging on recycling. On the trends are quite obvious because they have an impact on not only the product packaging, labeling, definition, not material usage, but also an impact on the production systems. So how do you make those happen with new materials. On here, our Loxitan is a good example of that. They are facing many challenges.
Transformation of the production system. The new customer behavior I've talked to you about, margin pressure that's or true for more or more sold sectors regulation and compliance is increasing from that standpoint, as well as, of course, new ways to deliver. Loxetan is a good example of that here. And you see what we are doing for the production system. OMA Lifestyle, you remember the acquisition of Sampi Plin.
We don't know, 100% of it yet, this should happen in the next 18 months, 2 years, the dynamic is remarkable in terms of new brand acquisition. We are really quite impressed with that and the relationship is excellent with the team, and they are maybe leading on their market. I think it speaks for itself when you look at the number of logos on the footprint they are taking here are the incredible dynamic in terms of, branding adoption. The portfolio of sampling PLM is expanding from organization of the product collection, timing sourcing, but also on the capacity for collaborative negotiation process happening between the commercial aspect of it on the collection development, more to be discussed when we will do the full year review. So in that sector, where are the impact from a business value standpoint?
It's really the to increase the performance or use inventory and reduce the cost of logistic. Now if I go on and move on another sector where we said that we will redefine the standard is the construction sector. I believe that we are making significant wins in that sector, what we call, territory infrastructure and construction, because this sector is far behind in terms of digitization. And it's about project management, it's about the right way to do modeling simulation of construction before you actually do it. A big showcase here and construction, I think in my mind, so much is happening in China.
We are focusing in China. We're focusing in India, and we are focusing in projects around the world, but in some way less in developed countries and much more in developing countries. This is CRVC. They are doing the entire infrastructure. With the 3DEXPERIENCE platform watch this video that illustrates well what they do.
China Railway Design Corporation is the only comprehensive grade a survey and design institute under China Railway Corporation. The Corporation pioneered 90 industry first since its establishment in 1953. A good standard is required to ensure a comprehensive life cycle of railway engineering construction. Hence, the standard being referred to also requires software support. Dassault System's 3 d experience platform is based on a single platform and design library, and is well suited for our Moreover, we can enable many design disciplines to co design on a unified platform, the 3 d experience, flat form is the gold standard due to open this support of the China Railway standards.
The 3DEXPERIENCE platform is not only used for its 3d design, but more importantly, it is integrated with the management platform. Managers can access various data from the management console and have clear visibility into the design process us.
A short summary of what was never done before. This is, in the construction sector, huge, huge CapEx, huge OpEx, for predictive maintenance of the installation later on in the life cycle. And we are redefining the beam standard in China for China. And I believe that new beam standard, which is 3 d sound centric, will have an effect on the rest of the world. Another example here is a lot of RTX now seeing the value of cloud based before they were using very simple low cost software, the names on the brand names and the fact that they can have platform based mobile, is a big difference for them.
Here is another showcase of an architect using the 3DEXPERIENCE platform.
Co Architects is renowned for its extensive portfolio of large and complex institutional Civic Academic, Medical Education And Science And Technology, as well as healthcare projects. Digital continuity really allows for the clear communication of project goals, the vision, as well as the intended execution throughout the process. To ensure everyone involved understands what they're working towards and need to ultimately achieve. At every handoff, to a different discipline or different trade contractor. And at every switch and deliverable medium, whether shop drawing fabrication model, mock up or other, the risk of departure same model is used by the repository and can evaluate the impact on the project goals immediately and collectively.
The 3 d experience platform brings us much closer to complete digital project documentation across all disciplines and scopes to work. Overall, it supports our approach at co architects of using technology not just for increased value, but also with meaning, with purpose to improve long term performance and minimize the impact on the environment, while creating innovative, impactful and last architecture.
So we are expecting in short this leadership in this market from 2 extremes, architects redefining the way they work with their supply. An extremely large complex program, like infrastructure, on section of cities, on more to come in this area or railways, So those are 2 extremes coming together in the middle today. That is a very conservative industry, and we believe that the platform phenomena will change the game here too. So it's a quite good fun time to see all this happening and the potential is significant from that standpoint. On Life Science briefly, the different challenges are well formulated today about whether it's personalized health, capitalization of knowledge and know how for not only education, but improved practices, total quality and the safety.
And of course, the development, especially in biologics, on the connection between R&D Research Development And Manufacturing Biologics complexity of large molecules is to produce them in a reliable way. And of course, closing the loop with the upcoming connection with Medidata for clinical trials. So you can imagine that our platform is more than digital continuity. It's about connecting all those to do a comprehensive assessment on targeting on deliver solutions, which are relevant to the disease that they are targeting to solve. This is an illustration here of, with a company called IRBN on where they are basically, doing research using the bio solution that we just read the Experience Platform with a solution that we call OneLab.
And the OneLAN platform is used there to increase speed and efficiency, to improve compliance on quality, on the proof points that they can follow the right processes of course, tasks, execution, standardization, training and tracking of what people are doing in those processes. And we are reducing massively the customized software they've been using in the past. It's a good trend, and it's something that will not stop in that sector. It's at the beginning of a new phase. It's more than document based.
It's a platform simulation based process tracking. GC Pharma same, same approach here for research to manufacturing with the same objectives, speed, quality, time to market and compliancy on putting the collaborative process at the heart of what they do. And this is, again, the one lab designed to cure solution. As you notice, we are now naming the solutions for what they do, and not for the functionality they have, so the value versus the capabilities. Medidata Acquisition of Pascal will give you more information.
Whether or not we would have got the CPUs last night, we knew it was coming. It was a clerical process that was a little bit longer. So for me to see someone in vacation, so you cannot get the signing. But so it can happen in America. And, but this acquisition now is going to be closed in a few days, and Pascal will tell you more.
But the positioning of what we're doing together is very clear. And I think it's represented here in a very, hopefully useful and comprehensive way for you. In the health care and pharma sector, it's about 20 to Sadia behind all those sectors of the industry from a digitalization, most of what is done up to now is digital documents. It's not digital production digital research or digital development, its digital document everywhere. At best, We want to change that.
As we did when we did the digital airplane, digital car, digital train, on all this, which is to create a platform where from research discovery to preclinical development clinical testing, validation on manufacturing process, compliance and safety,
up to
the commercialization. We not only have a digital continuity of documents, but we have real digital experience that are the proof points that what is being invented, developed, reproduced, is targeting the right results from an health care and practices on results. So the blue things are what we have been focusing in the last 14 years with bio intelligence, then the serious acquisition on the creation of Biovia. And in those transformation, it does not go fast. It's a slow process, especially when you touch research and development, but we are there, and there is no other competitor.
By the way, to have other competitors, you need science based platform. That understand organic unknown organic modeling and simulation. There's also a platform on the market for that. That's the blue part The beautiful aspect of what Medidata has been doing as a world leader in clinical trial is connecting the pieces that we are not there, which is the confrontation between virtual and rear, which is happening at the time of clinical trial. So there's no overlap, 0 overlap.
It's a high complementarity, and I believe that this is going to be something which is going to be perceived. And we already know that customers are welcoming this, we have positive feedback from their side, from our side. And on that that's a quite interesting thing. So the brand is very well positioned. It says what it is, maybe data.
It's an intensive data for medical sector on biologics. So in our famous compass orientation, to not lose the orientation, when you look at us, it's on the east side, which is the power of information intelligence, which is the case for clinical trial, It's clear on our industry core focus from the framework we did And it's also very key from the way we reach on the market, looking at the number of companies in medical device, med tech, on as well as, of course, the companies in the pharma sector. So this is this is, I think, a move that, 1st of all, we love it. I think we mutually love it. We think there is something to be done here, and we think that the current landscape has been underserved.
I'm doing it together. We can do something different. With that, I think I give the floor to Pascal, to give you more illustration about the aspect of financial result, Pascalio on the floor and more of the strategy too.
Thank you, Bernard. Good morning to all of you. So let's start with the business review first for Q3. So I will qualify Q3 as a solid quarter because if you look at the number, 10% growth for the total revenue, an improvement of the operating margin by 140 basis points and 20% growth for the EPS and delivering In fact, the higher range of the target for the EPS and probably $0.02 to $0.03 more than the consensus. Why it's a solid quarter because the drivers, for the growth drivers are in play 9% growth for the software, and it's mainly driven by the 3DEXPERIENCE platform.
And I put the number for Q3 and the year to date So you see 19% growth for the Q3 and 32% growth in the beginning of the year. On the total software and for 3 systems platform. And if we zoom on the license, 21% growth for this quarter and 40% growth in the beginning of the year. And now the 3DEXPERIENCE platform is representing a 77, sorry, percent of the total software revenue and 40 3 percent of the total license revenue. So clearly, the 3 different platforms being the commerce on the strategy, these indicators, if KPIs, in fact, is well in place and the momentum is very good.
The second message on the software growth you notice it, the recurring revenue is accelerating. If you compare to last year, it's more than three points. And the organic growth for the recurring revenue is exceeding 10% this quarter. So there is maybe, Some business model changing. We'll see if the trends continue because if you look at the, since the beginning of the year, the growth of the recurrent revenue is to sort of extend a little bit more CDs and the license.
And this growth, and I will give you more detail afterwards, It's not only the result of the good super high maintenance activities, but it's also because the subscription is accelerating as well. In Q3, the subscription is close to 20% year over year. The last point is, yes, we are seeing some volatility on the license. And you see it, it's 2% growth for this quarter. 9% for the full year.
So it's still good for the full year, but for this quarter, we have seen some volatility, and this volatility is coming from the Sleep Age. In fact, the last 3 weeks of the quarter, we have seen a number of deals shifting from Q3 to Q4. Surprisingly, to understand, I was surprised because it's not in the auto sectors. I remember telling you that We were cautious with the auto sectors and especially the supply chain. But this volatility was coming from, you know, aerospace, life science, and Machine Building, where you see with Bernard's presentations, this is where the business is going very well.
So if we zoom on the regions, what can we see? So Americas is growing 19% 17% since the beginning of the year. And in Americas, all the drivers are really delivering effects. They are finding the large deal you have seen Luke Martin for this quarter. The recurring revenue is accelerating, mainly driven by the simulations.
And we have some contribution of the recent acquisition we did IQMS last year and Centric as well. But nevertheless, from an organic standpoint, the growth for this quarter is 14% for Americans. Europe, growing at 5%, 9% since the beginning of the year. And Europe, to some extent, you have, you can slice in two pieces. You have a good performance in France, the Nordics, including UK, and the 3rd part of Europe, where the growth is exceeding 10%.
In fact, to be more precise, the 14% for the south park 11% for the North part and 9% for France. And the sort of left hand, the contact performance is coming from Germany. So it's not you. We already have seen it in Q2, but it's still the case in Q3. Asia, 4% growth for this quarter, 7% growth for the full year, and almost the same story China continued to deliver as well as Japan, by the way, with a 10% growth for this quarter, for the since the beginning of the year, for for China, we are exceeding 15% growth.
And, but this growth is partially offset by some weak results in Korea and India, being largely impacted by the supply chain in the auto sectors. If we move to the product line, Catya is growing at 5% this quarter, compared to 8% in the beginning of the year, and you remember 9% for the first half. And this quarter, Kathy has been impacted by this volatility 0 to supply chain sectors. That's the reason why you have seen this growth. But keep in mind that the growth for CATIA is still steady in the larger OEMs because as Bernard pointed, we still need to electrify their car you cannot do this with CATIA V5, you need CATIA V6 to make it happen.
And we see a good performance in all this, what we call, CATIA Cyber all the set of applications dedicated to design the embedded systems and also the system of systems, including no magic, acquisition we did recently. Innovia growing at 3%, 10% in the beginning of the year. You remember, the end of year performance is intrinsically linked to the size of the transactions. So Q3 is probably, qualified by the fact that We do not have too much large transactions. We have a bunch of mid sized transactions.
And this is the reason why you have this 3% but overall, the trend is still good for Innovia, and we continue to win market share. Solid works, 5% since the beginning of the year, 7%. So I think it's a good sign. You remember, we had this discussion for the 1st semester, Sully was growing at 4%. And I told you that I was still confident that on the second half of the year, we could reach the 7, 8%.
So this is a proof. The growth is coming mainly from Asia, where we see a double digit growth, partially worse, but we have seen some improvement in Europe and America where we start to be back on growth. Other line, we call it other software, growing very nicely at 17% for this quarter 'nineteen, since the beginning of the year, you have a double digit growth for Simulier as well as DELMIA. So clearly, the momentum in simulations and the momentum in the manufacturing Atlas is still very good. And the simulations contribute a lot to the improvement of the WILTI, the solution set.
If I zoom on SOLIDWORKS, because it was one of the questions you had last quarter, I just want to remind you that for SOLIDWORKS, the The potential for the growth is still there. With SOLIDWORKS, we are targeting 1,500,000 for company. Today, the market share is 22%. So we are reaching 1,000,000 commercial license with SOLIDWORKS. But you still have 40% of the market still using 2 d.
Every year, you have between 3% to 4% of this market, migrating from 2 d to 3 d, which, and on this, we are roughly a 50% market share. And in average, a company moving from 2 d to 3 ds had 4 seats. So every year, we have 40,000 new license coming from the migration from the 2 d to 3 d. On the other part, you have 60 percent of the of this 1,500,000,000, companies using the 3 d systems,
and we are gaining market share.
In fact, with SOLIDWORKS, we are gaining market share against the competitors, we are gaining roughly one point every year. So 20,000 new license are coming from there. And the remaining, which is roughly 20,000 license, is coming from the large installed base we have extending their usage. So my point to you is the potential for growth is still there. And you have the details.
There is a second layer of SOLIDWORKS. In 'nineteen, we will reach 1,000,000 commercials license, in production. I'm excluding the indications side and the academics, where you could probably add 2 additional millions. For those guys, There is a lot of value to connect them with 3D Expense platform. And this is the plan for our next year.
Because this will automatically bring an additional value to them. Today, if you look at those guys, they are using sometime Dropbox, you know, some community things, some chat systems, All those basic capabilities are inside the platform available and Cadaware, meetings that it's embedded into the systems. Plus, as soon as you deploy the platform, we have the leverage to sell to them the additional new category of products we have developed for these markets. You remember that Mira Works, the IQMS acquisitions, we did few a few months ago to expand the scope in the manufacturing site. The simulation is becoming critical also for this midsized company And the fact that we have the computing for us available on the cloud, the fact that we could have the marketplace to get access to specialists, to help them to do this installation is opening these sectors and, for sure, the product life cycle capabilities provided by Innovia.
So we have 2 legs to continue to sustain the growth for SOLIDWORKS. So this is, I think, still a valid course drivers for the future for Lasso System. The Manufacturing, I just want to highlight this win because, if you remember, I heard some rumor related to Essence. But here, you have the proof. You know, those guys, they continue to expand with us.
And, and why so? Because 5G, it's a big opportunity for Cancksons, as you know, but there is a window for them to take this market. And the type of equipment they are developing are highly configurable because it's a mix between software, hardware and the services. It's not the volume production. I mean, it's a midsize theory they have to produce.
So the ability to reconfigure the production systems, accordingly, is super critical. And this is the reason why they are decided to deploy all the manufacturing solutions with us. If we zoom to the financial highlights for this quarter to go quickly, so you have seen total growth in terms of total revenue, 10%, 12% in the beginning of the year. From an organic standpoint, the organic growth For this quarter, it's 8%, 9% seen the beginning of the year. And if we zoom on the software, the growth 9% for the Q3, 11% in the beginning of the year, and it's 7% organic for the total software.
For Q3 and 9% in the 8% sorry, since the beginning of the year. If we split the revenue, the software revenue is the 2 different pieces, The license is growing at 2% for this quarter. From an organic standpoint, it's minus 1% and it's related to the volatility I just explained to you. To give you an order of magnitude, now we had almost 10 deals representing 1,000,000 to shift from Q3 to Q4. And we had also an additional tenders, representing almost 10,000,000 we were expecting to close.
So this give you an order of magnitude of the volatility. I'm still expecting to close them in Q4. And by the way, we put some incentives to be able close them, before end of November. But the key point is related to the subscriptions, you will see 10% organic growth for the total recurring software, 9% in the beginning of the year, and 17% for the subscription. So clearly, you have the details about the fact that the subscriptions, the recurrent part and, is really going nicely for us.
And maybe, the business model is changing. So we have probably it's too early to see it. We have to see a little how it will continue to evolve in the next quarters. But for sure, Medidata will add a significant subscriptions contributions to the model, and we will exceed 80% of the recurrent revenue, in the coming years. On the EPS side, 20% growth, sorry, the services.
I was moving to jump directly to the APS. So the services activity is really steady, 21% growth for this quarter. And you remember, last year, we were suffering services because we had to do the setup to be able to deploy all the last transaction we signed in the last 18 months. Now the team is in place, the structure is in place, and you see the benefits because the growth in the beginning of the year is 23%. And you also see the improvement on the gross margin because we are gaining, you know, we are almost doubling the gross margin on the services side compared to last year.
The operating margin, Android and 40 basis point improvements 200s coming from the organic side. So, and it's the result of the mix, the more you have recurrent revenue, the model leverage you have on the operating margin. Another percent basic point coming from the dilution of the acquisitions, specifically Centric and IQMS. And you have a contribution, a positive contribution of 40 basis points from the currency for this quarter. Which lead to the EPS growth, 20% for the quarter, 19th in the beginning of the year, and it's direct consequences of the top line growth and the improvement on the operating side.
For the cash flow,
and as you know, now the cash flow is becoming critical given the fact that we have a debt So we are exceeding the billions for the 9 months, and the growth is 33 34% in the beginning of the year. So clearly, we are doing in 9 months what we did in the year of last year. So and the and the cash flow growth is really driven by the net income and her ability to manage a working capital. So you have the details and you will see it's relatively explicit. Coming to the financial cost, I am sharing this with you because this will help you to modelize Q4 and also year 2020.
So you have the detail for, you know, the bonds and, especially the borrowing rates and the maturity. So you could expect to have 9,000,000 costs for year 2019 for Q4. And 41000000 for 2020. So with this, I think you have the details. And and we will be able to do the modernization properly.
If we move to the guidance, so Here is the key messages. So we before adding Medidata, we confirm our growth objective to 10 to 11% growth for the full year. The exchange rate and you have the details. And after we are adding Medidata, and just because we received the CFIUS confirmation last night, I took as an assumption that we would be able to close before October 31st or at least at the latest at the end of the month. Meaning, you will have 2 months contributions of Medidata for Q4.
And here, you have the details. So if you take the previous guidance, you had the Q3 and the Q4 are currency effects. It's $42,000,000 additional revenue. And you have the, the guidance. To take into account the volatility, I have slightly enlarged the range So you remember, we used to communicate with the 30,000,000 range.
Here, I put 40,000,000. I do not have the feeling that I'm cheating. Why so? Because you remember, when we were at 1,000,000,000 revenue, we were already, adding a range of 1,000,000 1,000,000,000. This is what we do within a quarter.
So I think it's appropriate to start to enlarge a little bit the range. And then you have the contribution of Medidata for 2 months. It's 103,000,000 in euro, not in USD. And we are lending to this new guidance, which is 1,000,000,000, 1,000,000,000 to 100000055000000 for year 2019. On the EPS side, the same exercise the currency effect is adding 510.
So now the guidance is 3.50to3.55 without BD data, meaning that we are delivering the 5 years plan without BD data, and this is the Zoho range the 350 is now becoming the low range of the guidance. And Medidata will add the $0.02 for the for Q4. And for the full year. So now the new guidance is between 3, we have 53 to 357. So with this, you have the details.
So I already commented the revenue side for the full year. In term of EBIT margin, we are expecting to reach the 32%. So pretty stable compared to last year, and you have the details about the organic improvement. The tax rate will be relatively consistent since the beginning of the year. And you have the EPS growing at 13% to 15%.
For Q4, the range will be on the revenue side between 1,000,000,000 172,000,000 to 1,000,002,121,000,000. And you have the details between the software license and the recurring parts. Obviously, in the recurring, you have the contribution of BD Data So this is the reason why we are almost doubly the performance of the recurring. The license, I took into account this volatility And this is the reason why you have, on the lower range, the fact that we could expect to be flat compared to last year, But I remind you that last year was the Q4 was an outstanding quarter from a license standpoint because we signed a lot of big deals. And I'm still expecting any way, given the pipeline we have, given also the deal shifting from Q3 to Q4, the ability to overperform compared to last year by 5% on the new license, which means a software growth of between 15% to 19%.
EBIT margin, 32% to 33%, sorry, to 33.5%. The dilutions coming from Medidata is around two points, which means an EPS of 1 5 to. With this, I think you have a pretty good view about, the quarter, the details, the business momentum, the guidance. And I invite you to attend the Life Science day, November 13th, to have all the details about, how we're managing the life sciences and what's next between the combination of Medidata and Dassault System. Thank you.
It's Adam Wood from Morgan
Stanley. Could I ask a couple, please? Maybe just first of all, you brought up the topic of solid work. So maybe if we could dig a little bit into that. And I wanted to discuss First of all, on the technology side, when you're delivering SOLIDWORKS as a cloud solution to customers, is that a native cloud solution of SOLIDWORKS that you're delivering On the kernel shift, is that now complete?
And how does the data compatibility work from the older versions of solidworks to ones that are going to be on the newer kernel? And kind of where are you with the platform shift of enabling you talked about next year when we actually have that platform availability and the crossover and then maybe linked to that PTCs obviously make quite a big move overnight buying on shape. They're discussing the disruption they can bring in that sector. Could you maybe just describe a little bit how you see that being different to your own purchase of Solid Works many years ago that went on to disrupt that market significantly and why it's going to be more or less difficult for them to do the same thing. And then just secondly, on the fourth quarter guidance, it's a pretty big slowdown organically from what we've seen year to date.
Could you maybe just give us a little feel, is that natural conservatism Or is that seeing a really big shift in the environment and the macro? And I suppose really it's less important for Q4, but more important when we look to 2020? Because this is the 1st tough quarter from a comp basis that you're facing. Obviously, you've got tough comps for most of 2020. Should that be a concern for us?
Thank you, Adam. The, on the first question related to the portfolio of, on evolution of SOLIDWORKS, simply said we offer 3 things. First of all, the SOLIDWORKS desktop installed base is gigantic which is almost a work stand out for mechanical system. So what do we offer to them? Solution number 1, you can use the platform on the cloud to power what you have.
So you, what we call Collaborative Innovation. On the cloud, you connect the desktop to the cloud and you can do collaborative process, solution number 1. Solution number 2 is, what exists for, Katya with 3DEXPERIENCE. Native common kernel, as you mentioned, as you follow us carefully, there is an evolution on longer term, we, mid term, we will support both Parasolib and Cachiya kernel for SOLIDWORKS usage. So solution number 2 is a tighter connection with the cloud platform.
So you can do simulation online, you can do manufacturing online on supplement wet solid waste does. That exists to solution number 3, which exists on these in its market introduction. Is browser based native design tools, Ala SOLIDWORKS experience, on the platform. We call it 3 d creator. It was called EX Design in the beta testing in the last 12 months.
So this is exactly at to add with on shape. To make it simple, I think for on shape, it's too late. We have far more licenses even on a browser today than what they can refer to. On, we we will see. I mean, I love race.
I love formula 1. I love race and, I love sport. This is going to be a sporty win, but I think, simply said it's too late. We are already there on the compatibility that we offer between the three things, desktop, the power of the 3Dx with all the solutions we have for enterprises. The position we have with median end users already in education, Hub Labs.
I remind you that for the MI T fab foundation, the software standard is Dassault Systemes with the experience on solid Nothing else. And this is going to be 5000 touch points across the world of fab labs, with the MIT program. So so, this would be a good try. But I'm very confident that, should have been done before, too late.
Coming back to your second questions, Adam, No. I think I took some cautiousness, and I see it explicitly because remember, I met with you guys almost a month ago. And I was, pretty confident on the pipeline for for Q3, but we see this volatility. And I want to take into account this volatility, and this is the reason why maybe you can see the Q4 numbers being a little bit child. But I think it's much better to deliver than to be.
The second point is, at the end, The commitment we took in front of you was to deliver the 350. And we took this commitment 5 years ago, And now I'm telling you that the low range of my guidance is to deliver 350. And I remember, 9 months ago, 8 months ago, some of you are still having doubt about our ability to deliver it. Including you, Adam.
So I think we accept doubts. We work on the doubts too because we listen to you. So
I think you have the pipe is good for Q4. It's probably the questions behind this. So the pipe is good. We had large transactions in the pipe, in almost all the different sectors, including 0 two sectors. And the China contribution is still also outstanding.
So if you look at what has been the goal drivers in the beginning of the years, we all had those goals diver in the pipeline for Q4. Thanks.
It's Mohammed Malawi from Goldman perhaps maybe you wanted to drill into the recurring dynamic because that is now starting to accelerate. To what extent, you talked about subscription growth accelerating. How do you see the resilience and more importantly, the growth of this as you move into next year? And is there also a sort of a structural shift, away from, from license purchasing to recurring that you think could be more pronounced as we move next year and the extent to which you obviously signed up a lot of big customers with big, big contracts. How is that sort of coming through?
So as you look into next year, I don't know if it's a bookings or something you can give us that this could be a kind of underpinning at least your kind of expectations in the next year? And then Second question, Bernard, is when you sign Boeing, we've obviously then seen this on network effects with, obviously, Lockheed today, but airbus, etcetera. So in the auto sector, obviously Toyota is quite a sort of significant development. How do you sort of see those sort of network effects? You talk about Japanese autos, but more broadly, for you in terms of sort of pushing the platform
through. Thank you more for this question. I really let Pascal provide insight on the first question. I just want to make one comment, Pascal and I, on the team, we are and you are aware of that. We are working very hard to clarify the way we should present our results going forward, not now, but at the beginning of 2, when we initiate the next program, in early 2020 for three reasons.
Which are embedded in your question. First, there is an obvious reason, which is the event of many data, on the fact that we've been reporting on CATIA solid works, should we present it in different way with industry view? So that's one factor, right? The second factor is exactly to your point, evolution of the nature of the subscription model with many data, again, but we're also cloud. And even the nature of contract with large clients when they want to do the network effect with supply.
And they want to say, well, you shouldn't acquire the entire platform. For my entire ecosystem, and then it creates a new way to engage with them. So we have made the decision, and it's not a big reveal, but that we will, adjust that way of presenting the results to provide you with the proper visibility to address those questions, which are really implying the view of booking versus evolution of recurring. So but we think this is a good news. This is a good news because it shows the, where we are transforming the business model of the company on, we are very comfortable doing that.
That's the background. So we are just, it would be easier to discuss that February that now Millet Pascal has some comments on it. I will come back on the same question.
So more it's probably a little bit early to to give you guidance for 2020. And let's finish 1st the year. But nevertheless, you may remember, in the recurrent revenue, you can slice into different pieces. You'll have the maintenance and support, representing 2 SIR, and the SIRR is coming from the subscriptions. So the subscription is growing for this quarter at 17%.
So clearly, high double digit And the contribution is the simulation, because the vast majority of the simulation is under substance. The cloud has been our say the network effects for the supply chain. And also, we see more and more large customers using the specialized application with the subscription model. I was mentioning products like No Magic now being part of Catia. You have a bunch of customers willing to go on subscription for this kind of applications.
So those are the reason why the quickly taking off to a certain extent or accelerated. Next year, you remember, Boeing is accelerating the deployments. So I'm still expecting to have, you know, a few percentage coming from there. On the super admittance side,
the levers in the mix,
and 3 extents platform represent 27 percent of the total software revenue. But you remember, the maintenance rates between 3DEXPERIENCE platform and V5 is an improvement from 18% to 21%. So the more mix we have the more contribution we have from the 3 different platforms, for it, the more levers we have also to accelerate this growth.
I am still seeing
the 3 different platforms continue to grow next year due to the large deployments. So the three points you have seen, this year, pretty confident those three points will not disappear.
To the second question, the network effect. I think we have, I have, we have, we have discovered an interesting market dynamic There is a lot of new startups in each of the sectors, which we consider as our core sectors. You have a lot of players in e mobility You have seen latest announcement for even air, electrical mobility. We are extremely successful with cloud on the external platform. In fact, the external platform is adopted by almost all of So that's one piece.
In the middle of that, you have the Tier 2, what we call Tier 2 and Tier 3, suppliers of Big OEMs. They have been, adopting a good dynamic for 3 d experience. The slower speeds, which, you know, were related to the OEM transformation itself. So that's why we and that's, by the way, across all large sectors. That's why we insist today on the relevant of those decisions, which are made because, it's not the purchase order.
It's the decision effect of, of those players. They are both of them on the, all, the one we have referred to, they have a big influence on the market. So I believe that newcomers tier 2, tier 1 on the connection with OEMs on the OEMs adopting a platform approach, provides long term, midterm and long term visibility for the snowball effect. And I think that's why with, Pascal, we need to structure the way we report, for the next 5 years before more but, in a way that living that in a more accurate way, which is not done to them.
Good morning. It's John King from Bank of America.
I'm just a couple of calls.
Questions as your follow-up on the last
point, just with the Toyota deal, can you go into
a little bit more detail as to what's changing there over and above and taking a new version? Is there any competitive displacement or new scope or is it more cases, I guess, the higher pricing that you would charge for the 3 d experience applications? And then perhaps just one question for Pascal on the cash flows obviously been very, very impressive this year. Maybe just couple of thoughts about what we can expect for the full year because obviously it's running well ahead of net income right now. So how sustainable is that or should we expect some weakness in Q4 to compensate?
So thank you for the question about the Toyota. It's not an update of software. It's not even necessary, replace 1 of existing solution. It's a full transformation of the way the company is working. Many of those big players still have incredible legacy of software.
I think for those of you who are following the banking, many banks are earning infrastructure, which are forty years old. But you have to know that with this big OEMs, the legacy for what they were calling the bond management. Those are very old system. In the case of Toyota was only willing to cigarettes, we are replacing 2 gigantic, database systems. That are managing their data flow across the group on the plans.
So it's a new, in fact, we, in our communication, we say PowerBuy, because it's to make sure that we express that it's not even the replacement of V5. It's the expansion of the entire backbone in an area we have never been And by the way, none of the players have been, none of the players on the market today have been, except the old infrastructure from IBM and all occur but really what I call database oriented system. And we are replacing all those systems. Most of the OEMs today are in that situation. So it's a big footprint expansion, and that footprint expansion is creating the very positive context for the adoption of the industry solutions in a second step.
Same thing at Boeing. You remember, it was called the CAC MRM, a strange name for something that was a huge legacy data environment for what the production systems that we're replacing. So it's a expanded footprint. We mentioned 40,000 users, but ultimately, it's going to touch almost everyone in the company. So this is where we see the clear lever.
And of course, changed the rules for our production systems, as you know, the manufacturing engineering at Toyota is very powerful. In fact, it's the core of the router, on the adopting that approach. Okay.
And maybe I would add a few few words because I know that you want to move to do some modeling. So it's forty thousand people. We're going to have to equip over the next 5 years. So the The project is supposed to finish in year 2023. And, it's divided by slice equally.
Points per year. And, it's a €1000 per, per seat. Okay. So it should be easy for you to compute the number. Coming back to the question on the call,
And this is without counting. This is a power buy only is a power buy. You must understand that this is not the replacement CATIA or the replacement of the application for DELMIA or the replacement for SIMULIA and all those things, which will come on top of that. So we're talking about contracts that should be similar to the Boeing size, ultimately, for different companies of that size.
For the cash flow for the full year, again, if you look at the contributions, the levers, it's mainly coming from the net income. The net income with the guidance I gave to you should be able to compute it. So we have some improvements on an organic standpoint. And the DSO you saw our DSO, moving, you know, used to peak at, exceeding 80, 80 days. And now we are back to 77, if I remember well.
And we expect to stabilize this a little bit because This, this, I would say, improvement of the DSO is coming from the fact that the recent acquisition, we are putting the disciplines, and they didn't have this ability previously And also, there is something which you have to take into account, depending the country, you have payment terms, which are slightly different. The best being the German, for sure, the worst, the Chinese. So the more growth you are coming from China and the less growth you are coming from Germany could slightly impact DSO. But yes, you could expect to have, a trend which is similar.
We'll take one last question for the moment from the room and then we'll take it from on the call.
Yes. Thank you very much. It's James Goodman from Barclays. So my first question was just around the clear optimism you have on the construction industry actually. And the way in which you described that is something of a fundamentally different approach to some of the vendors that we follow in that space.
So I was just curious whether you think that you have the full product set to address that market in the way in which you want to, whether there's a disproportionate multi year organic investment that needs to go into that or whether there would be acquisitions considered in due course? And the follow-up question, just on the quarter, it's just the inclusion of Medidata the number was slightly lower than what I anticipated for the quarter, particularly given phasing. So maybe if you could just comment whether there's any conservatism baked into that or anything should consider in terms of the final quarter from a metadata perspective?
You're right on the fact that the construction is going or significant transition. It's a conservative sector. The showcase we have now or the touch points we are now showing that our solutions are rather complete. If you transform your process, to leverage them. In concrete term, in the architecture, we presented last time.
We presented the Zadig showcase, the Arab showcase. Now they are also customer area. Those they are doing gigantic programs, in the case of Zai adding, it's this new gigantic airport in China. And it's not only about the shape of the airport. It's the entire flow on construction infrastructure and it has, it is having an effect on the engineering and procurement and construction of those gigantic infrastructure young buildings, same as CARDC, what you saw is not a video just to represent this, or every details of this infrastructure are done with our platform.
So the however, the solution can provide this kind of very significant outcome performance in cycle cost reduction and manual project management, like what we did with margin downward, by the way, in oil and gas, as long as you transform the business processes. So I think the biggest slowing factor for market adoption is going to be related to the capacity for those players to transform themselves, which we don't plan to do need to from the past. We don't plan In some way, 30 years ago, the same exact thing happened in manufacturing. When Boeing decided to paper 7, with 3 d master. It was not drawing production.
It was 3 d master. And then it went through BMW It went through all the other actors outside aerospace. I we want to replicate that. So yes, there will be expansion, there will be investment that we will need to continue to do, but in the new way of doing business, not in the old way. So don't don't be concerned about any move, acquiring legacy things, in this area, I more doing things that which have not been done before.
On Medidata, yes, we Ruben and I, Rouven, is the CFO and the COO of BD Data in the room. So maybe you can ask the question directly to you, but we took some cautiousness because when you are integrating to company, usually you are creating some defocus. And we want to be sure that, you know, he will not be penalized by that. Now there is one indicate our equity share with you because BD data will not release the Q3 numbers. The incremental annual contract value, which is really the key indicator for them, grew at 15% in Q3, which is a good sign of the quality of the business.
It will be bad to start on a roll. Ambience or the ambience to be positive going forward. Thank
you. It's Charlie Brennan here from Credit Suisse. Can I just ask 2 clarifications around topics that have already been discussed today? Firstly, it sounds like at the margin, there's been some switch from or license to subscription. Are you able to quantify that for us?
And do we need to think about that when we start to do our modeling for 2020, I know you would typically want to aspire for 10% license growth, but do we need to think about that structural dynamic when we think about 2020? And then secondly, you're signing up more and more of these large multi year platform deals. I'm assuming that starts to give you, at some point, an order book, and some future license visibility. Are you able to give us a sense of how much of your typical quarterly license is coming from in quarter deals versus some of these multiyear deals that you may have signed in prior quarters?
Okay. So a lot of questions in 2. We It's not only the exercise to do, what you are asking, but we try to do it. So theoretically speaking, if you do the math, one point in YLC equal at least 4 to 5 points subscription, sorry, equals at least 4 to 5 points in new license, if you do the math. Okay.
But the more important we try to modelize, you know, the acceleration of the way and see of the subscription for this year and what is the equivalent of the new license or what would have been the equivalent of the new license. So we did this exercise. It's not pure, it has not been audited. So clearly take it as a as much more a way to understand the phenomenon. So we are convinced that it's an equivalent of 6 point of July 2.
In Q3 or yesterday?
Yesterday. Came on year to date. Because, again, the difficulty is the growth from 1 quarter to another one, you should you should not come twice. So we did the same for the 1st 9 months. The second question you ask, again, it's I understand it's difficult for you to do
the modeling. On this
because you have no clue about the renewal dates. You don't know the size. You have no view on the incremental size of the subscriptions. But the multi years, you know, with a new IFRS, constrained, we have put a strict rules to the Salesforce. We do not want them because it's maybe good for 1 year, But you pay the full price the year after because you recognize almost 2 third the year of the signing.
So to avoid to be in these situations, we have put a very strict discipline with the salespeople. We say, guys, we want to have multi years but we want to be in a position to do it on a yearly basis, not to have to artificially, infuse growth within a year and then pay the full price to the year after.
Okay. We'll move to the call, Brian. Do we have questions on the call? Brian? Operator?
Yes, sir. Your first question. It's from Julian Teraheini from Jefferies.
Hi, thank you for taking my questions. Just one question on the deal slippage. I think Vasquez, you had mentioned putting in place incentives to get deals closed by starting November, if
you don't make a way.
So can you give more detail on what incentives are you talking about? Or commission to a sales representative. This is discount 8. Can you explain that a little more, please?
Oh, it's only a commission. And inside the rules, Iberdock can confirm when the customer is not signing in a given quarter, we increase the price And it's not, so it's only commission
Okay.
Your next question is from Nicholas Davis from ODDO CHS. Your line is open.
Yes. Hi. Good morning. Thank you for taking my question. Actually, I have 2 regarding your profitability.
Regarding your Q4, guidance. So it implies a profitability, which is down between 10101 bps excluding the data. I understand that you have a subscription migration which is not helping, but do you have something else or
so which is waiting on your
margin guidance? And my second question is more to Q1.
Also regarding to 17 and the subscription is
ramped up. And the cloud ramp
up, actually, could you share with us your profitability, I just want to know that you're able to deliver on your cloud revenue in Italy? More or less in one way that you can do in a on premise set, and or should we expect that kind of an issue? Yeah. Very much.
Okay. So I will start with the second part of your question. So the profitability is equal. Whatever it's on premise on the cloud. It's easy.
And the second, the first question you asked me related to the profitability for Q4, In fact, you remember, we were late in the hiring since the beginning of the year. And in fact, half starting September and especially in Q3, we hire a lot of people, especially in research and development. The reason is because during the summer, have all the internship, it's a good way for us to test new candidates, like, to select them. And usually, we are hiring them in within between September October. So in Q4, you have the full effect of this, and this is the reason.
And if you take your follow-up on the subscription and cloud margin, do you plan like a lot of stuff companies to maybe capitalize on cost in around that a little bit,
the potential impacts of your,
the delay of revenue and your profitability. Like sales commission costs and so on?
So we are not doing it, clearly. I already answered this question. And by the way, It's one of the discussion we had with Medidata because, we will expense all the R and D costs day 1. And for the sales commission, as far as we are concerned, that's the system we are not doing it. DD data, they are doing it.
And we have to take into account the way we want to treat it for 2020.
Okay. Thank you very much.
And your next question from Alex Talp from Deutsche Bank. Your line is open. You may ask your question.
Could you just I don't know if you mentioned this, quantify the impact on licenses from Lockheed and Toyota in the quarter and kind of the cadence that you expect around license or whether those are majority subscription deals, looking forward? And then secondly, I see that the inorganic contribution this quarter to licenses was quite a lot less than last quarter, 3% this quarter. Versus 5% last quarter. But I recall you saying that July is a very large month for Centric normally. And you have the impact from IQMS.
So is there something that I'm missing there? Why has that contribution in organic fallen so much in the third quarter? Thanks.
Okay. So we'll answer to the second questions. Remember the date when we are quite centric? It's almost a year. So next quarter it will become organic.
Okay. So this is what we did. We did a pro rata conference for the quarter. And this is the reason why the contributions of the external growth seems a little bit below. That's the reason.
Now coming back to Toyota. I think I will really answer to the questions.
And the question was for our look in the unfolding budget questions.
And Lockheed, you know, it's, it's
a large deal. It's
close to 10,000,000, license. So it's a license deal. It's not a subscription deal. Well as for Toyota. And you could expect to have the subscription part of these deals over the next few years.
And again, the fact that Lucky that decided to deploy the 3DEXPERIENCE platform means that obviously, we have other opportunity with them.
Yes. This is a very beginning of, it's only on, one secured program. So it's they have a lot of programs.
Great. Thanks. So just to be clear, from the license portion of those deals did fall in Q3 and it was around about 1,000,000.
No, not at all. Not at all.
Okay. So when did it
Yeah. I I I already answered the question. So it's 10,000,000 in Q3.
Right. From just from Lockheed or from Lockheed and Toyota?
Toyota, you have no revenue in Q3.
We'll take one last question from the
Thank you. Your next question comes from the line of Stacy Pollard from JP Morgan. Your line is open. You may ask your question.
Hi, thanks for taking the call. I've dropped out of the call a few times by accident. So I hope this hasn't already been asked or answered. But just a quick one. What is maybe 2 long term opportunity in automotive?
How well penetrated is 3 d experience across the various OEMs and supply chain? And how much do you think you have to go? And then second question, do we need to and I think this was touched on a little bit, but I ended up dropping off just the question about margin evolution as we look at the shift from sort of towards cloud and subscriptions versus license. How do we need to think about that in the coming years in terms of organic margin?
Thank you for the question. On the auto sector, I believe that The midterm long term is bigger than everything we have done from the past 30 years. Because the platform effect is all the new things we are doing are domains that we had not covered yet in the past power buy for Toyota is a good example. It's a massive change in their infrastructure of legacy. And on top of that, you have all the modernization of what would be simplified by saying the V5 portfolio going V6 portfolio on the platform, the 3DEXPERIENCE platform.
So the potential insured for the auto sector is very, very large. It's more, depend on the speed at which they transform their legacy environment. But I think the Toyota decision has The other that were communicated shows that they are not acting like in the banking sector using forty years old software. They are going through this new next generation platform based, infrastructure. So, usually be concerned about the potential.
The valid question is about the speed, but of the potential it's there.
And related to the EBIT margin moving forward, Again, it's probably a little bit early to speak about 2020, but you have to take into account the 2 mechanisms, including the dilutions coming from Medidata. So at this stage, what I can say to you, we will not be below 30%.
I guess that's a start. And again, any sense of, you talked about the percentage point difference in license 1 versus 4 to 5 subs versus license. Any way to quantify that around margins or maybe too early?
Remember, Stacy, the margin is the same, whatever it's a subscription or a cloud. Or a non premise.
We'll take the last question from the room, Michael.
Thank you, Francois. I'm Michael Breese at UBS. 2 from me, I'm afraid as well. Just firstly, on the subscription business. I mean, the guidance for Q4 for a business which is twice as large as license, you've got the same range.
So it's 25% to 28% versus 0% to 5% just in terms of how you book the subscription revenue, it's not always ratable, is it sometimes you would book some of it if you like upfront splitting the revenues between occurring element and a sort of instantly recognized piece. Is that right?
No. Again, with the new accounting rules, you know, you have to recognize upfront an equivalent of the license, during the quarter when you do the renewal on signing, but it's neutral for the full year. There is no discrepancy, except if you sign multiyear contract and you've committed your customers, that I've been very explicit about it. Those for the sales people is fine to have multi year contracts, but we do not want to have this accounting mechanisms whereby we're going to recognize 2 serve of the subscription within a year and then pay the price, the 2 or 3 years out term. So the the the number is acting, Michael?
No. No. I wasn't saying suggesting
we weren't just to clarify the the And then,
but not just on the macro environment, obviously, there was were these deals slipped quite late in the quarter? It seemed to be in multiple sectors and countries. How do you feel about the world today, and your sort of outlook into 2020, not talking guidance terms But what's going to drive an improvement if you, if you like relative to what we saw in September?
As Pascal said, I think we have a very good visibility for the Q4. The news flow about those deals and those decisions I think will create, but it's too early to speak about it, a quite good visibility for 2020. Yes, we see like you, the news flow from the global economy, about tension in different sectors and so on. The reality is, in the sectors that we have commented more specifically today, auto and aerospace, we want to simply share with you the fact that for us,
we clearly
see growth in 2020, and we are comfortable with the dynamic. That's why we insisted on those, on those deals, because we do recognize your concerns from this sector news flow. This morning, in an interview, I mentioned that, keep in mind that all those players, they have to redefine their portfolio for the next 5 years and it's a lot of work. And they need new type of solutions on the need to simplify our R and D development process on a vehicle architecture, mobility architecture are changing rather quickly. So it's not just like doing a new model year, which we think is where we can help them in a big way.
So more to be discussed in early next year where we want to really set a new 5 years plan. You have already some inputs about it. On, I think mid mid November, we will give you the specific, program for, Healthcare on life science, 2 weeks from now. With that. Thank you very much.
Thank you for your participation. And we are having fun, even though the economy is staffed. Which is the most important thing in life.